German manufacturer Schott has opened new ready-to-use (RTU) centre for pharmaceutical packaging at its production facility in Lebanon, Pennsylvania, US.
The new centre is expected to serve as a hub for the company where experts from the company and its pharmaceutical partners will co-operate for innovations.
Schott has started production of adaptiQ ready-to-use vials at the facility.
The facility is aimed to innovate solutions that can leverage the full potential of sterile packaging concepts.
The production facility’s capacity will also ensure the security of supply of RTU vials and other pharma packaging products at the centre.
Pharmaceutical partners for Schott, which manufactures around ten billion packaging products annually, include Bausch + Ströbel, GEA Lyophil, ARaymond Life and West Pharmaceutical Services.
Schott Pharmaceutical Systems US sales and marketing vice-president Christopher Cassidy said: "Packaging is a critical cog in pharmaceutical delivery, and recent regulatory papers highlight the importance of high-quality processing and manufacturing of packaging.
"SCHOTT’s centre of excellence in Lebanon is the manifestation of the relationship we have with our partners, and our collaborative efforts create safe, reliable, and easy-to-use packaging products."
The centre was launched at an event in which experts from pharmaceutical industry highlighted how speciality drugs are supporting medical growth in developing countries, and the self-administered drug market is expected to grow by 100% within next five years.
To ensure safety of packaging, pharmaceutical manufacturers are focusing on RTU packaging as it can allow for particle-free drug filling, filling different container formats on the same filling line, and also turn processing of smaller batch sizes cost-effective.
Image: Schott started production of adaptiQ nested vials at the centre. Photo: courtesy of SCHOTT.